A note from the founder

Why Medibridge exists.

Lin Wang · 2026
Jing'an Office · 2024

My father was on a waiting list for a procedure that ten Shanghai surgeons could have performed the next week. The barrier was not money, and it was not capability — it was information.

Medibridge exists to remove that barrier for other families. We are a small team, by choice. We accept no commissions from hospitals. Every cost is disclosed in writing. Every case file passes our medical director's desk before it goes to a hospital.

If you write to us, you will get a personal reply within one business day — from me, or from someone whose name appears on this page.

Lin WangFounder & Managing Director · Shanghai
Founded2019
Team14 FT
Cases1,200+
Who you'll work with

Four named operators. Ten more behind them.

14 Full-Time · Jing'an Office
Lin WangFounder & Managing Director

12 years in cross-border healthcare M&A at a tier-1 Shanghai PE firm. Built the original referral network with Fudan-affiliated institutions in 2019.

Dr. Sarah Park, MDMedical Director

Internal medicine, board-certified (US & KR). Reviews every case file. Former hospitalist at NewYork-Presbyterian.

Marco BianchiHead of Patient Logistics

Formerly with a Geneva-based medical evacuation service. Coordinates visas, hotel, transport. On-call from arrival to departure.

Yuki TanakaTranslation & Records Lead

CMI-certified medical interpreter (English & Japanese). Builds the bilingual record packets returned to your home physician.

In the press

External coverage.

2023–2025
CGTNMar 04, 2024

Cost-effectiveness and clinical outcomes at China's elite institutions now rival, and in some specialties surpass, their Western counterparts — drawing a quiet flow of international patients to Shanghai.

South China Morning PostNov 18, 2023

For high-acuity surgery, the Shanghai pathway is no longer an outlier. The barrier is information, not capability — services like Medibridge are closing that gap with concierge-grade coordination.

China DailyAug 22, 2024

A small but growing referral channel routes Western patients through Shanghai's Class 3A network — translated records, S2 visas, and continuity handed back to home physicians on return.

Patient outcomes

Three of twelve hundred.

Used with consent · names verified
Total knee replacement−$32,800

After being quoted $47,000 in Houston, Medibridge connected me with Dr. Chen at Zhongshan. Total cost including flights and two weeks recovery: $14,200.

Coronary bypass · CABG−$89,000

My Toronto cardiologist quoted an 8-month wait. Medibridge arranged everything in three weeks. The surgeon had performed over 3,000 bypass procedures.

CAR-T cell therapy−$318,000

Quoted $380,000 for CAR-T therapy in the US. Medibridge found a Shanghai team doing the same treatment for $62,000 — visa, translation, and follow-up handled.

Have a question about your case? We reply within one business day.

Begin assessment